US Patent 10973891 Treatment and prevention of remote ischemia-reperfusion injury
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+278 characters)
Article
Patent abstract
The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
109738910
Date of Patent
April 13, 2021
0Patent Application Number
163595980
Date Filed
March 20, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 27 Mar, 2023
Golden AI
Infobox
Edits on 28 Sep, 2022
Golden AI
Infobox
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
109738910
Date of Patent
April 13, 2021
0Patent Application Number
163595980
Date Filed
March 20, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10973891 Treatment and prevention of remote ischemia-reperfusion injury
Infobox
Is a
Patent jurisdiction
Patent number
10973891
Date of patent
April 13, 2021
Patent application number
16359598
Date Filed
March 20, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10973891 Treatment and prevention of remote ischemia-reperfusion injury
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
